Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

Despite recent advances in the treatment of children with acute megakaryoblastic leukemia (AMKL) using intensified treatment protocols, clear prognostic indicators, and treatment recommendations for this acute myeloid leukemia (AML) subgroup are yet to be defined. Here, we report the outcome of 97 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweitzer, Jana, Zimmermann, Martin, Rasche, Mareike, von Neuhoff, Christine, Creutzig, Ursula, Dworzak, Michael, Reinhardt, Dirk, Klusmann, Jan-Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488462/
https://www.ncbi.nlm.nih.gov/pubmed/25913479
http://dx.doi.org/10.1007/s00277-015-2383-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488462/
https://www.ncbi.nlm.nih.gov/pubmed/25913479
http://dx.doi.org/10.1007/s00277-015-2383-2

Ejemplares similares